Biotechnologies Assets SA (BST.MC)

EUR 0.29

(-5.84%)

Operating Expenses Summary of Biotechnologies Assets SA

  • Biotechnologies Assets SA's latest annual operating expenses in 2023 was 840.45 Thousand EUR , down -88.11% from previous year.
  • Biotechnologies Assets SA's latest quarterly operating expenses in 2023 FY was 516.09 Thousand EUR , down -88.11% from previous quarter.
  • Biotechnologies Assets SA reported a annual operating expenses of 4.34 Million EUR in annual operating expenses 2022, down -5.07% from previous year.
  • Biotechnologies Assets SA reported a annual operating expenses of 4.57 Million EUR in annual operating expenses 2021, up 17.28% from previous year.
  • Biotechnologies Assets SA reported a quarterly operating expenses of -813.27 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.
  • Biotechnologies Assets SA reported a quarterly operating expenses of 1.21 Million EUR for 2023 Q3, up 249.42% from previous quarter.

Annual Operating Expenses Chart of Biotechnologies Assets SA (2023 - 2010)

Historical Annual Operating Expenses of Biotechnologies Assets SA (2023 - 2010)

Year Operating Expenses Operating Expenses Growth
2023 840.45 Thousand EUR -88.11%
2022 4.34 Million EUR -5.07%
2021 4.57 Million EUR 17.28%
2020 3.89 Million EUR -87.64%
2019 31.54 Million EUR 11.58%
2018 28.27 Million EUR 701.0%
2017 3.52 Million EUR 7.14%
2016 3.29 Million EUR 41.63%
2015 2.32 Million EUR 1.81%
2014 2.28 Million EUR 107.38%
2013 1.1 Million EUR -34.99%
2012 1.69 Million EUR 56.43%
2011 1.08 Million EUR 23.19%
2010 879.46 Thousand EUR 0.0%

Peer Operating Expenses Comparison of Biotechnologies Assets SA

Name Operating Expenses Operating Expenses Difference
Atrys Health, S.A. 143.61 Million EUR 99.415%
Oryzon Genomics S.A. 18.49 Million EUR 95.456%
Pharma Mar, S.A. 152.36 Million EUR 99.448%
Laboratorios Farmaceuticos Rovi, S.A. 263.09 Million EUR 99.681%